Senate Bill 440
116th Congress(2019-2020)
PACED Act
Introduced
Introduced in Senate on Feb 12, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
440
Congress
116
Policy Area
Commerce
Commerce
Primary focus of measure is business investment, development, regulation; small business; consumer affairs; competition and restrictive trade practices; manufacturing, distribution, retail; marketing; intellectual property. Measures concerning international competitiveness and restrictions on imports and exports may fall under Foreign Trade and International Finance policy area.
No Senate votes have been held for this bill.
Summary
Preserving Access to Cost Effective Drugs Act or the PACED Act
This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.
Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.
06/28/2019
Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
06/28/2019
Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.
06/27/2019
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
02/12/2019
Read twice and referred to the Committee on the Judiciary.
02/12/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 4:02:58 PM